Cite
HARVARD Citation
Adiamah, M. et al. (n.d.). MEDB-79. MYC-driven upregulation of thede novo serine and glycine pathway is a novel therapeutic target for Group 3 MYC-amplified Medulloblastoma. Neuro-oncology. p. i125. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Adiamah, M. et al. (n.d.). MEDB-79. MYC-driven upregulation of thede novo serine and glycine pathway is a novel therapeutic target for Group 3 MYC-amplified Medulloblastoma. Neuro-oncology. p. i125. [Online].